Skip to content

The effect of Ocimum on sleep and cognitive function

The effect of Ocimum Hydro Alcoholic Extract on Cognitive Function and Sleep Quality in patients with Choronic Obstructive Pulmonary Disease: A randomized controlled clinical trial

Status
Recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20150919024080N15
Enrollment
96
Registered
2020-03-03
Start date
2019-12-22
Completion date
Unknown
Last updated
2020-03-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic obstructive pulmonary disease. Other chronic obstructive pulmonary disease

Interventions

Intervention 1: Intervention group: In this group, 60 basil capsules will be taken by patients at a dose of 300 mg once daily at 22-22 hours, one to two hours before bedtime, and with a glass of water

Sponsors

Khoram-Abad University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
40 Years to 80 Years

Inclusion criteria

Inclusion criteria: Male and female patients 40 to 80 years old and residing in Khorramabad city Sleep disorder with a high score of 5 (based on Pittsburgh Sleep Disorder Questionnaire) Cognitive dysfunction score below 26 (based on Montreal Cognitive Impairment Questionnaire) No history of allergy to ocimum extract Minimum literacy and ability to understand Persian language

Exclusion criteria

Exclusion criteria: Illness, unstable hemodynamic status, life-threatening arrhythmias Affected by neurological diseases, cancer, acute infection and known mental disorders (anxiety, depression and delirium) The need for sleep medications (such as benzodiazepines, etc.) during the study Hospitalization during the study Participate in other Nairobi yoga and meditation cardiopulmonary rehabilitation programs Sensitivity to ocimum Extract for 2 consecutive days during study and non-use of ocimum Extract Capsule

Design outcomes

Primary

MeasureTime frame
Cognitive performance score. Timepoint: Before the intervention, and one week after the 60-day treatment period. Method of measurement: Montreal Cognitive Impairment Questionnaire.;Quality of sleep score. Timepoint: Before the intervention, and one week after the 60-day treatment period. Method of measurement: Pittsburgh Sleep Quality Questionnaire.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactSeyed Reza Hosseini Fard

Khoram-Abad University of Medical Sciences

reza.hfard@yahoo.com+98 916 018 4818

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026